Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-89.44	51.53	-488.18
Graham Fair Price	-35.46	2.25	3.48
PEG	257.23	0.38	-0.11
Price/Book	16.79	2.96	2.53
Price/Cash Flow	46.10	-12.03	8.24
Prices/Earnings	172.49	-54.59	20.03
Price/Sales	47.17	1.81	1.23
Price/FCF	46.10	-12.03	8.24
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.66	0.06	0.07
Operating Margin	-83.70	< 0.005	-0.03
ROA	-53.37	< 0.005	< 0.005
ROE	0.03	-0.01	-57.14
ROIC	0.18	< 0.005	-97.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	1.16	-95.44
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-10.22	1.13	-88.97
EPS QOQ	1.87	-1.42	-23.72
FCF QOQ	78.92	-1.79	-97.73
Revenue QOQ	0.17	-0.22	30.02
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.30	67.87	7.22
Days Sales Outstanding (DSO)	55.92	62.75	12.21
Inventory Turnover	1.42	1.33	-6.73
Debt/Capitalization	0.26	0.34	34.04
Quick Ratio	0.60	0.55	-8.08
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.13	4.07	-1.42
Cash	3.99	3.23	-18.99
Capex	-0.21	-0.14	31.56
Free Cash Flow	1.27	-1.00	-21.20
Revenue	8.51	6.66	-21.77
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.97	0.97	-0.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	108.85	-3.09	-97.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating